Characterization of hydroxymethylnitrofurazone compounds as inhibitors of Leishmania mexicana cysteine proteases (2013)
- Authors:
- Autor USP: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF
- Unidade: FCF
- Subjects: LEISHMANIA MEXICANA; INIBIDORES DE ENZIMAS
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Bioquímica e Biologia Molecular (SBBq)
- Publisher place: São Paulo
- Date published: 2013
- Source:
- Título do periódico: Abstracts
- Conference titles: Annual Meeting of the Brazilian Biochemistry and Molecular Biology Society (SBBq)
-
ABNT
JESUS, L. O. P et al. Characterization of hydroxymethylnitrofurazone compounds as inhibitors of Leishmania mexicana cysteine proteases. 2013, Anais.. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular (SBBq), 2013. . Acesso em: 21 maio 2024. -
APA
Jesus, L. O. P., Trossini, G. H. G., Juliano, L., Coombs, G. H., & Judice, W. A. de S. (2013). Characterization of hydroxymethylnitrofurazone compounds as inhibitors of Leishmania mexicana cysteine proteases. In Abstracts. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular (SBBq). -
NLM
Jesus LOP, Trossini GHG, Juliano L, Coombs GH, Judice WA de S. Characterization of hydroxymethylnitrofurazone compounds as inhibitors of Leishmania mexicana cysteine proteases. Abstracts. 2013 ;[citado 2024 maio 21 ] -
Vancouver
Jesus LOP, Trossini GHG, Juliano L, Coombs GH, Judice WA de S. Characterization of hydroxymethylnitrofurazone compounds as inhibitors of Leishmania mexicana cysteine proteases. Abstracts. 2013 ;[citado 2024 maio 21 ] - Synthesis of inhibitors of sirtuin 2 for chagas disease
- Synthesis, molecular modeling and docking studies of nitrofurazone analogues as trypanomicine candidates
- Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides
- Building and validation of a pharmacophore model of LSD-1 inhibitors for virtual screening
- Quantitative structure-activity relationships (HQSAR, CoMFA and CoMSIA) studies for a COX-2 selective inhibitors
- Construction and validation of the CPB2.8 model and pharmacophore model design of cysteine proteases
- An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors
- Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases
- The survey of the use of QSAR methods to determine intestinal absorption and oral bioavailability during drug design
- Pharmacological evaluation and preparation of nonsteroidal anti inflammatory drugs containing an N-Acyl hydrazone subunit
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
